1. SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma. (1st August 2022) Authors: Li, Bin; Ren, Mei‐Yu; Chen, Yu‐Zhen; Meng, Yu‐Qi; Song, Tie‐Niu; Su, Zhi‐Peng; Yang, Bo Journal: Journal of gene medicine Issue: Volume 24:Number 8(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗